Back pain is one of the most common health problems in the world. It can begin after lifting something heavy, sitting for long periods, an injury, or simply from changes in the spine that happen with age.
For many people, the pain improves within days or weeks. But others develop chronic back pain that lasts for months or years and can make working, sleeping, exercising and even ordinary household activities difficult.
One possible cause is degenerative disk disease. The spine contains soft disks between the bones, or vertebrae, and these disks act like cushions that help absorb pressure and allow the back to move.
As people get older, the disks can lose water, become thinner and develop damage. These changes do not always cause pain, but in some people they are linked to ongoing lower back pain, stiffness and reduced movement.
Treatment often begins with exercise, physical therapy and medicines for pain. Some patients receive injections, while people with severe symptoms that do not improve may eventually be considered for surgery.
Now, researchers are studying a different approach that attempts to treat the damaged disk itself. Dr. Douglas Beall and colleagues at Clinical Radiology of Oklahoma have investigated a treatment known as viable disk allograft supplementation.
The procedure involves injecting specially prepared donor tissue containing living cells into a damaged spinal disk. The aim is to support the disk and possibly encourage changes that could improve its condition, rather than simply reducing the feeling of pain.
The treatment is performed through a needle, making it much less invasive than major spine surgery. Patients can generally leave after the procedure instead of facing the longer recovery associated with an operation.
Early results have attracted attention. In a study involving 50 people with long-lasting lower back pain caused by disk degeneration, about 60% of participants who received the treatment had at least a 50% reduction in pain.
About 70% also experienced a meaningful improvement in their ability to carry out everyday activities. These benefits suggest that some patients who have struggled with chronic pain could potentially gain both pain relief and better physical function.
The approach may also be important because chronic back pain is one reason some patients use opioid pain medicines. Opioids can provide powerful short-term pain relief, but longer use carries risks including dependence, tolerance, overdose and other side effects.
A treatment that provides lasting relief without regular opioid use could therefore have important benefits. However, researchers still need to determine exactly how the injected tissue works and which patients are most likely to respond.
The early findings should also be interpreted carefully. A study involving only 50 people cannot show how well the treatment will work across the much larger and more diverse population of people with chronic back pain.
Larger studies and longer follow-up will be needed to confirm the benefits, identify possible risks and determine how long the improvement lasts. Researchers will also need to compare the treatment with other available options.
The research on viable disk allograft supplementation was published in Pain Physician. If future studies confirm the early results, the procedure could eventually offer another option for some people with painful degenerative disk disease who have not improved with standard care.
If you care about health, please read studies that vegetarian women have higher risk of hip fracture, and these vitamins could help reduce bone fracture risk.
For more health information, please see recent studies that Krill oil could improve muscle health in older people, and Jarlsberg cheese could help prevent bone thinning disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
